According to NuVasive's latest financial reports the company's current revenue (TTM) is $1.22 B. In 2022 the company made a revenue of $1.20 B an increase over the years 2021 revenue that were of $1.13 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.22 B | 2.02% |
2022 | $1.20 B | 5.53% |
2021 | $1.13 B | 8.41% |
2020 | $1.05 B | -10.06% |
2019 | $1.16 B | 6.02% |
2018 | $1.10 B | 7.01% |
2017 | $1.02 B | 7.01% |
2016 | $0.96 B | 18.61% |
2015 | $0.81 B | 6.39% |
2014 | $0.76 B | 11.27% |
2013 | $0.68 B | 10.47% |
2012 | $0.62 B | 14.75% |
2011 | $0.54 B | 13.02% |
2010 | $0.47 B | 29.13% |
2009 | $0.37 B | 48.08% |
2008 | $0.25 B | 62.1% |
2007 | $0.15 B | 57.29% |
2006 | $98.09 M | 58.75% |
2005 | $61.78 M | 60.9% |
2004 | $38.4 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Medtronic MDT | $32.32 B | 2,535.73% | ๐ฎ๐ช Ireland |
Stryker Corporation SYK | $20.96 B | 1,609.55% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | $0.74 B | -39.11% | ๐บ๐ธ USA |
Globus Medical GMED | $1.56 B | 27.91% | ๐บ๐ธ USA |